JPET Introducing ALZET?ew Model 2006 Pump

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Tao, P. L.
Right arrow Articles by Loh, H. H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Tao, P. L.
Right arrow Articles by Loh, H. H.

Decrease in delta and mu opioid receptor binding capacity in rat brain after chronic etorphine treatment

PL Tao, PY Law and HH Loh

The modulatory effect of continued activation of opiate receptors with agonist on the receptor level was examined in current studies. Rats were rendered tolerant to etorphine by s.c. implantation of osmotic minipumps containing 3 mg/ml of etorphine for up to 7 days. During this period, there were a time-dependent increase in the AD50 values of etorphine to inhibit the tail-flick response and an increase in naloxone-precipitated withdrawal signs. When these animals and others were sacrificed and the opiate receptor binding properties were examined, it could be demonstrated that there was also a time-dependent decrease in the amount of [3H]diprenorphine specifically bound, with maximal attenuation reached 3 days after implantation. There was no alteration in alpha 2 adrenergic receptor binding. This observed decrease in [3H]diprenorphine binding was not due to the presence of nonwashed etorphine in the membrane, for acute administration of the same dose of etorphine before sacrificing did not produce an attenuation of the opiate receptor binding. Further examination of opiate receptor binding in the brain regions of cortex, midbrain and striatum revealed the greatest decrease in the amount of [3H]diprenorphine bound in striatal region after chronic etorphine treatment, a 68% decrease. When the relative decrease in mu and delta opioid receptor binding was determined by carrying out [3H]-D-Ala2, DLeu5-enkephalin binding in the presence of 1 microM morphiceptin, it was observed that, 3 days after etorphine treatment, there was a decrease in mu opioid receptor binding, with minimal change in delta opioid receptor binding in both brain regions of striatum and midbrain. Only in cortex was a decrease in binding of both receptor subtypes observed.(ABSTRACT TRUNCATED AT 250 WORDS)

Volume 240, Issue 3, pp. 809-816, 03/01/1987
Copyright © 1987 by American Society for Pharmacology and Experimental Therapeutics




This article has been cited by other articles:


Home page
J. Pharmacol. Exp. Ther.Home page
S. P. Hume, A. R. Lingford-Hughes, V. Nataf, E. Hirani, R. Ahmad, A. N. Davies, and D. J. Nutt
Low Sensitivity of the Positron Emission Tomography Ligand [11C]Diprenorphine to Agonist Opiates
J. Pharmacol. Exp. Ther., August 1, 2007; 322(2): 661 - 667.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
H. Haberstock-Debic, K.-A. Kim, Y. J. Yu, and M. von Zastrow
Morphine Promotes Rapid, Arrestin-Dependent Endocytosis of {micro}-Opioid Receptors in Striatal Neurons
J. Neurosci., August 24, 2005; 25(34): 7847 - 7857.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
P. Riba, Y. Ben, A. P. Smith, S. Furst, and N. M. Lee
Morphine Tolerance in Spinal Cord Is Due to Interaction between {micro}- and delta -Receptors
J. Pharmacol. Exp. Ther., January 1, 2002; 300(1): 265 - 272.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
D. L. Cichewicz, V. L. Haller, and S. P. Welch
Changes in Opioid and Cannabinoid Receptor Protein following Short-Term Combination Treatment with {Delta}9-Tetrahydrocannabinol and Morphine
J. Pharmacol. Exp. Ther., April 1, 2001; 297(1): 121 - 127.
[Abstract] [Full Text]


Home page
J. Neurosci.Home page
L. J. Sim-Selley, D. E. Selley, L. J. Vogt, S. R. Childers, and T. J. Martin
Chronic Heroin Self-Administration Desensitizes {micro} Opioid Receptor-Activated G-Proteins in Specific Regions of Rat Brain
J. Neurosci., June 15, 2000; 20(12): 4555 - 4562.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
P.-Y. Law and H. H. Loh
Regulation of Opioid Receptor Activities
J. Pharmacol. Exp. Ther., May 1, 1999; 289(2): 607 - 624.
[Abstract] [Full Text]


Home page
J. Pharmacol. Exp. Ther.Home page
L. M. Harrison, A. J. Kastin, and J. E. Zadina
Tyr-W-MIF-1 Attenuates Down-Regulation of Opiate Receptors in SH-SY5Y Human Neuroblastoma Cells
J. Pharmacol. Exp. Ther., February 1, 1998; 284(2): 611 - 617.
[Abstract] [Full Text]


Home page
J. Biol. Chem.Home page
A. Kovoor, V. Nappey, B. L. Kieffer, and C. Chavkin
µ and delta  Opioid Receptors Are Differentially Desensitized by the Coexpression of beta -Adrenergic Receptor Kinase 2 and beta -Arrestin 2 in Xenopus Oocytes
J. Biol. Chem., October 31, 1997; 272(44): 27605 - 27611.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
J. J. Chen, J. Dymshitz, and M. R. Vasko
Regulation of Opioid Receptors in Rat Sensory Neurons in Culture
Mol. Pharmacol., April 1, 1997; 51(4): 666 - 673.
[Abstract] [Full Text]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 1987 by the American Society for Pharmacology and Experimental Therapeutics.